A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis

Todd C. Crawford, David R. Okada, J. Trent Magruder, Charles Fraser, Nishant Patel, Brian A. Houston, Glenn J. Whitman, Kaushik Mandal, Kenton J. Zehr, Robert S. Higgins, Edward S. Chen, Hari Tandri, Edward K. Kasper, Ryan J. Tedford, Stuart D. Russell, Nisha A. Gilotra

Research output: Contribution to journalArticle

  • 1 Citations

Abstract

Background: Patients with end-stage cardiomyopathy due to cardiac sarcoidosis (CS) may be referred for mechanical circulatory support (MCS) and heart transplantation (HT). We describe outcomes of patients with CS undergoing HT, focusing on the use of MCS as a bridge to transplant (BTT). Methods: Using the United Network for Organ Sharing Scientific Registry of Transplant Recipients, we identified all adult waitlisted patients and isolated HT recipients from 2006 to 2015. These were divided into those with and without CS and further divided into those who did or did not receive MCS as BTT. Outcomes included 1- and 5-year post-transplantation freedom from mortality and 5-year freedom from primary graft failure. Results: Over the study period, 31,528 patients were listed for HT, 148 (0.4%) of whom had CS. Among the CS patients, 34 (23%) received MCS as BTT. 18,348 patients (58%) eventually underwent HT, including 67 (0.4%) with CS, 20 (30%) of whom had received BTT MCS. Compared with non-CS diagnoses, CS patients had similar 1-year (91% vs 90%; log rank P =.88) and 5-year (83% vs 77%; log rank P =.46) freedom from mortality. Survival was also similar between CS BTT and non-CS BTT groups at 1 year (89% vs 89%; log-rank P =.92) and 5 years (72% vs 75%; log-rank P =.77). Conclusions: Survivals after HT were similar between CS and non-CS patients out to 5 years, and were also similar between CS and non-CS BTT cohorts. Both HT and BTT MCS should be considered in patients with CS.

LanguageEnglish (US)
Pages384-391
Number of pages8
JournalJournal of Cardiac Failure
Volume24
Issue number6
DOIs
StatePublished - Jun 1 2018

Fingerprint

Heart Transplantation
Sarcoidosis
Transplants
Survival
Mortality
Cardiomyopathies
Registries

Keywords

  • Sarcoidosis
  • heart transplantation
  • propensity score matching
  • survival analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis. / Crawford, Todd C.; Okada, David R.; Magruder, J. Trent; Fraser, Charles; Patel, Nishant; Houston, Brian A.; Whitman, Glenn J.; Mandal, Kaushik; Zehr, Kenton J.; Higgins, Robert S.; Chen, Edward S.; Tandri, Hari; Kasper, Edward K.; Tedford, Ryan J.; Russell, Stuart D.; Gilotra, Nisha A.

In: Journal of Cardiac Failure, Vol. 24, No. 6, 01.06.2018, p. 384-391.

Research output: Contribution to journalArticle

Crawford, TC, Okada, DR, Magruder, JT, Fraser, C, Patel, N, Houston, BA, Whitman, GJ, Mandal, K, Zehr, KJ, Higgins, RS, Chen, ES, Tandri, H, Kasper, EK, Tedford, RJ, Russell, SD & Gilotra, NA 2018, 'A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis' Journal of Cardiac Failure, vol. 24, no. 6, pp. 384-391. https://doi.org/10.1016/j.cardfail.2018.02.009
Crawford, Todd C. ; Okada, David R. ; Magruder, J. Trent ; Fraser, Charles ; Patel, Nishant ; Houston, Brian A. ; Whitman, Glenn J. ; Mandal, Kaushik ; Zehr, Kenton J. ; Higgins, Robert S. ; Chen, Edward S. ; Tandri, Hari ; Kasper, Edward K. ; Tedford, Ryan J. ; Russell, Stuart D. ; Gilotra, Nisha A. / A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis. In: Journal of Cardiac Failure. 2018 ; Vol. 24, No. 6. pp. 384-391.
@article{0ceff49c0084453991d424d1e59b7690,
title = "A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis",
abstract = "Background: Patients with end-stage cardiomyopathy due to cardiac sarcoidosis (CS) may be referred for mechanical circulatory support (MCS) and heart transplantation (HT). We describe outcomes of patients with CS undergoing HT, focusing on the use of MCS as a bridge to transplant (BTT). Methods: Using the United Network for Organ Sharing Scientific Registry of Transplant Recipients, we identified all adult waitlisted patients and isolated HT recipients from 2006 to 2015. These were divided into those with and without CS and further divided into those who did or did not receive MCS as BTT. Outcomes included 1- and 5-year post-transplantation freedom from mortality and 5-year freedom from primary graft failure. Results: Over the study period, 31,528 patients were listed for HT, 148 (0.4{\%}) of whom had CS. Among the CS patients, 34 (23{\%}) received MCS as BTT. 18,348 patients (58{\%}) eventually underwent HT, including 67 (0.4{\%}) with CS, 20 (30{\%}) of whom had received BTT MCS. Compared with non-CS diagnoses, CS patients had similar 1-year (91{\%} vs 90{\%}; log rank P =.88) and 5-year (83{\%} vs 77{\%}; log rank P =.46) freedom from mortality. Survival was also similar between CS BTT and non-CS BTT groups at 1 year (89{\%} vs 89{\%}; log-rank P =.92) and 5 years (72{\%} vs 75{\%}; log-rank P =.77). Conclusions: Survivals after HT were similar between CS and non-CS patients out to 5 years, and were also similar between CS and non-CS BTT cohorts. Both HT and BTT MCS should be considered in patients with CS.",
keywords = "Sarcoidosis, heart transplantation, propensity score matching, survival analysis",
author = "Crawford, {Todd C.} and Okada, {David R.} and Magruder, {J. Trent} and Charles Fraser and Nishant Patel and Houston, {Brian A.} and Whitman, {Glenn J.} and Kaushik Mandal and Zehr, {Kenton J.} and Higgins, {Robert S.} and Chen, {Edward S.} and Hari Tandri and Kasper, {Edward K.} and Tedford, {Ryan J.} and Russell, {Stuart D.} and Gilotra, {Nisha A.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.cardfail.2018.02.009",
language = "English (US)",
volume = "24",
pages = "384--391",
journal = "Journal of Cardiac Failure",
issn = "1071-9164",
publisher = "Churchill Livingstone",
number = "6",

}

TY - JOUR

T1 - A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis

AU - Crawford, Todd C.

AU - Okada, David R.

AU - Magruder, J. Trent

AU - Fraser, Charles

AU - Patel, Nishant

AU - Houston, Brian A.

AU - Whitman, Glenn J.

AU - Mandal, Kaushik

AU - Zehr, Kenton J.

AU - Higgins, Robert S.

AU - Chen, Edward S.

AU - Tandri, Hari

AU - Kasper, Edward K.

AU - Tedford, Ryan J.

AU - Russell, Stuart D.

AU - Gilotra, Nisha A.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Background: Patients with end-stage cardiomyopathy due to cardiac sarcoidosis (CS) may be referred for mechanical circulatory support (MCS) and heart transplantation (HT). We describe outcomes of patients with CS undergoing HT, focusing on the use of MCS as a bridge to transplant (BTT). Methods: Using the United Network for Organ Sharing Scientific Registry of Transplant Recipients, we identified all adult waitlisted patients and isolated HT recipients from 2006 to 2015. These were divided into those with and without CS and further divided into those who did or did not receive MCS as BTT. Outcomes included 1- and 5-year post-transplantation freedom from mortality and 5-year freedom from primary graft failure. Results: Over the study period, 31,528 patients were listed for HT, 148 (0.4%) of whom had CS. Among the CS patients, 34 (23%) received MCS as BTT. 18,348 patients (58%) eventually underwent HT, including 67 (0.4%) with CS, 20 (30%) of whom had received BTT MCS. Compared with non-CS diagnoses, CS patients had similar 1-year (91% vs 90%; log rank P =.88) and 5-year (83% vs 77%; log rank P =.46) freedom from mortality. Survival was also similar between CS BTT and non-CS BTT groups at 1 year (89% vs 89%; log-rank P =.92) and 5 years (72% vs 75%; log-rank P =.77). Conclusions: Survivals after HT were similar between CS and non-CS patients out to 5 years, and were also similar between CS and non-CS BTT cohorts. Both HT and BTT MCS should be considered in patients with CS.

AB - Background: Patients with end-stage cardiomyopathy due to cardiac sarcoidosis (CS) may be referred for mechanical circulatory support (MCS) and heart transplantation (HT). We describe outcomes of patients with CS undergoing HT, focusing on the use of MCS as a bridge to transplant (BTT). Methods: Using the United Network for Organ Sharing Scientific Registry of Transplant Recipients, we identified all adult waitlisted patients and isolated HT recipients from 2006 to 2015. These were divided into those with and without CS and further divided into those who did or did not receive MCS as BTT. Outcomes included 1- and 5-year post-transplantation freedom from mortality and 5-year freedom from primary graft failure. Results: Over the study period, 31,528 patients were listed for HT, 148 (0.4%) of whom had CS. Among the CS patients, 34 (23%) received MCS as BTT. 18,348 patients (58%) eventually underwent HT, including 67 (0.4%) with CS, 20 (30%) of whom had received BTT MCS. Compared with non-CS diagnoses, CS patients had similar 1-year (91% vs 90%; log rank P =.88) and 5-year (83% vs 77%; log rank P =.46) freedom from mortality. Survival was also similar between CS BTT and non-CS BTT groups at 1 year (89% vs 89%; log-rank P =.92) and 5 years (72% vs 75%; log-rank P =.77). Conclusions: Survivals after HT were similar between CS and non-CS patients out to 5 years, and were also similar between CS and non-CS BTT cohorts. Both HT and BTT MCS should be considered in patients with CS.

KW - Sarcoidosis

KW - heart transplantation

KW - propensity score matching

KW - survival analysis

UR - http://www.scopus.com/inward/record.url?scp=85044137929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044137929&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2018.02.009

DO - 10.1016/j.cardfail.2018.02.009

M3 - Article

VL - 24

SP - 384

EP - 391

JO - Journal of Cardiac Failure

T2 - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

SN - 1071-9164

IS - 6

ER -